Advertisement

PharmacoEconomics & Outcomes News

, Volume 840, Issue 1, pp 9–9 | Cite as

Cost effectiveness of dabigatran: value of real-world data

Non-clinical study
  • 2 Downloads

Reference

  1. De Pouvourville G, et al. The contribution of real-world evidence to cost-effectiveness analysis: case study of dabigatran etexilate in France. European Journal of Health Economics : 24 Oct 2019. Available from: URL: https://doi.org/10.1007/s10198-019-01123-5

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations